Clinical Trial Update: Mutation-specific Therapy for the Long QT Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a mutation-specific therapy for Long QT Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Qt Syndrome

Snippet

Sponsor: Istituto Auxologico Italiano | Conditions: Long QT Syndrome | Phase 2 | Status: COMPLETED